A New Zealand woman who went to China to get fetal tissue therapies for her ALS (motor neuron disease) has died. Allegedly, there was an early improvement and then she slipped back into the disease. This reminds me of the Korean umbilical cord blood patient who apparently got onto her feet after years of paralysis, only to see the treatment benefit short lived and then to suffer an infection upon a second therapy attempt.
For all of the hype about cures, it seems to me that much of this will be about alleviating symptoms. Which is a great thing. But we also have to be patient. Regenerative medicine needs to be worked through experimentally in animal studies and, when ready, controlled human experiments. Rushing into treatments before they have shown reasonable safety and efficacy could leave the patient worse off than before.
Undercover in Canada’s Lawless Abortion Industry
On November 27, 2023, thirty-six-year-old Alissa Golob walked through the doors of the Cabbagetown Women’s Clinic in…
The Return of Blasphemy Laws?
Over my many years in the U.S., I have resisted the temptation to buy into the catastrophism…
The Fourth Watch
The following is an excerpt from the first edition of The Fourth Watch, a newsletter about Catholicism from First…